₹233.5
(Inclusive of all Taxes)
₹35.0 Cashback (15%)
Prescription drugWhats That
46 people bought in last 30 days
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
உற்பத்தியாளர்/சந்தைப்படுத்துபவர் :
அஸ்கா பார்மாசூட்டிகல்ஸ் பிரைவேட் லிமிடெட்
உட்கொள்ளும் வகை :
வாய்வழி
திரும்பப்பெறும் கொள்கை :
திரும்பப்பெற முடியாது
காலாவதியாகும் நாள் அல்லது அதற்குப் பிறகு :
Jan-27
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Eritel-CH 6.25 Tablet:
Co-administration of Aliskiren with Eritel-CH 6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Eritel-CH 6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Eritel-CH 6.25 Tablet:
Co-administration of Eritel-CH 6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Eritel-CH 6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Taking Potassium citrate with Eritel-CH 6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Eritel-CH 6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Eritel-CH 6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Eritel-CH 6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Taking quinapril with Eritel-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Eritel-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Co-administration of amiloride with Eritel-CH 6.25 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Eritel-CH 6.25 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with Eritel-CH 6.25 Tablet:
Taking spironolactone with Eritel-CH 6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Eritel-CH 6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Co-administration of Eritel-CH 6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Eritel-CH 6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Taking Eritel-CH 6.25 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Eritel-CH 6.25 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Eritel-CH 6.25 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Coadministration of enalapril with Eritel-CH 6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Eritel-CH 6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Eritel-CH 6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Eritel-CH 6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Eritel-CH 6.25 Tablet:
Taking trimethoprim with Eritel-CH 6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Eritel-CH 6.25 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Taking trimethoprim with Eritel-CH 6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Eritel-CH 6.25 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Eritel-CH 6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Eritel-CH 6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Eritel-CH 6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Product Substitutes
மது
பாதுகாப்பற்றது
தூக்கம், தலைச்சுற்றல் மற்றும் கல்லீரல் பாதிப்பு போன்ற விரும்பத்தகாத பக்க விளைவுகளைத் தவிர்க்க நீங்கள் மது அருந்த வேண்டாம் என்று பரிந்துரைக்கப்படுகிறது மற்றும் Eritel-CH 6.25 டேப்லெட் 15's.
கர்ப்பம்
பாதுகாப்பற்றது
Eritel-CH 6.25 டேப்லெட் 15's கர்ப்ப காலத்தில் பரிந்துரைக்கப்படவில்லை, ஏனெனில் இது ஒரு வகை D கர்ப்ப மருந்து. இந்த மருந்து கருவுக்கு சேதம் விளைவிக்கும் மற்றும் பிறக்காத குழந்தையை (கரு) பாதிக்கலாம்.
தாய்ப்பால்
பாதுகாப்பற்றது
Eritel-CH 6.25 டேப்லெட் 15's தாய்ப்பாலில் கலக்கும் என்று அறியப்படுகிறது, ஆனால் குழந்தையின் மீதான அதன் விளைவு தெரியவில்லை. எனவே, தாய்ப்பால் கொடுப்பதற்கு முன், இதைப் பற்றி உங்கள் மருத்துவரிடம் தெரிவிக்கவும். Eritel-CH 6.25 டேப்லெட் 15's பயன்படுத்துவதற்கு நீங்கள் தாய்ப்பால் கொடுப்பதை நிறுத்த வேண்டும், அல்லது Eritel-CH 6.25 டேப்லெட் 15's எடுத்துக்கொள்வதை நிறுத்த வேண்டும்.
ஓட்டுநர்
பாதுகாப்பற்றது
எச்சரிக்கையுடன் ஓட்டுங்கள், Eritel-CH 6.25 டேப்லெட் 15's பொதுவாக தூக்கத்தை ஏற்படுத்துகிறது மற்றும் ஓட்டும் திறனை பாதிக்கிறது.
கல்லீரல்
எச்சரிக்கை
Eritel-CH 6.25 டேப்லெட் 15's எச்சரிக்கையுடன் எடுத்துக்கொள்ள வேண்டும், குறிப்பாக உங்களுக்கு கல்லீரல் நோய் வரலாறு இருந்தால். உங்கள் மருத்துவ நிலை மற்றும் சிகிச்சைக்கான உங்கள் எதிர்வினை ஆகியவற்றைப் பொறுத்து உங்கள் மருத்துவர் மருந்தளவை மாற்ற வேண்டும்.
சிறுநீரகம்
பாதுகாப்பற்றது
நாள்பட்ட சிறுநீரக நோய் (கடுமையான சிறுநீரகக் குறைபாடு) உள்ள நோயாளிகளுக்கு பரிந்துரைக்கப்படவில்லை. கடுமையான சிறுநீரகக் குறைபாடு உள்ள நோயாளிகளுக்கு பாதுகாப்பு மற்றும் செயல்திறன் நிறுவப்படவில்லை.
குழந்தைகள்
எச்சரிக்கை
Eritel-CH 6.25 டேப்லெட் 15's இன் செயல்திறன் மற்றும் பாதுகாப்பு குழந்தைகளில் நிறுவப்படவில்லை. பரிந்துரைக்கப்பட்டால், அது கண்டிப்பாக மருத்துவ மேற்பார்வையின் கீழ் இருக்க வேண்டும் மற்றும் நன்மைகள் தீங்குகளை விட அதிகமாக இருந்தால் மட்டுமே.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
